DETERMINATION OF THE PHARMACOKINETIC PROFILES OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 AND PROTEIN-2 IN RATS

被引:37
|
作者
YOUNG, SCJ
MILES, MV
CLEMMONS, DR
机构
[1] UNIV N CAROLINA, SCH MED, DEPT MED, DIV ENDOCRINOL, CHAPEL HILL, NC 27599 USA
[2] UNIV N CAROLINA, SCH MED, DEPT PEDIAT, CHAPEL HILL, NC 27514 USA
[3] UNIV N CAROLINA, SCH PHARM, CHAPEL HILL, NC 27514 USA
关键词
D O I
10.1210/en.131.4.1867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The insulin-like growth factor binding proteins (IGFBPs) are present in serum and alter the half-life of IGF-I and II in the vascular compartment. Because both IGFBP-1 and 2 have been proposed as regulators of IGF transport, we directly determined their distribution and elimination characteristics in rats. I-125-IGFBP-1 and 2 were injected into anesthetized normal rats. Multiple blood samples were drawn over time and the trichloroacetic acid precipitable radioactivity used to determine their pharmacokinetic profiles. The mean residence time for IGFBP-1 was 129 +/- 31 min and for IGFBP-2 116 +/- 24 min. The volume of distribution at steady state was 300 +/- 87 ml/kg for IGFBP-1 and 242 +/- 32 ml/kg for IGFBP-2. The elimination half-life was 120 +/- 26 min for IGFBP-1 and 144 +/- 32 for IGFBP-2. The results show that two separate methods of analysis give equivalent results for estimation of half-lives of these forms of IGFBPs and that their half-lives are substantially greater than that reported for free IGF-1, but less than that reported for the 150-kilodalton IGF complex. The findings suggest that these proteins equilibrate with extravascular compartments and may have a role in modulating transvascular transport of IGF-I and II.
引用
收藏
页码:1867 / 1873
页数:7
相关论文
共 50 条
  • [1] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1
    RUTANEN, EM
    SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1992, 10 (02): : 154 - 163
  • [2] DIMERS OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 AND PROTEIN-2 IN-VIVO AND IN-VITRO
    WIEHLE, R
    HILSENRATH, R
    ARUH, I
    CISNEROS, P
    POINDEXTER, A
    BIOLOGY OF REPRODUCTION, 1995, 52 : 90 - 90
  • [3] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 AND OVARIAN STIMULATION
    MARTIKAINEN, H
    TAPANAINEN, J
    RONNBERG, L
    KAUPPILA, A
    SELENIUS, P
    SEPPALA, M
    HUMAN REPRODUCTION, 1991, 6 (09) : 1220 - 1222
  • [4] EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 AND PROTEIN-2 GENES THROUGH THE PERINATAL-PERIOD IN THE RAT
    BABAJKO, S
    HARDOUIN, S
    SEGOVIA, B
    GROYER, A
    BINOUX, M
    ENDOCRINOLOGY, 1993, 132 (06) : 2586 - 2592
  • [5] STRUCTURE OF THE HUMAN INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 GENE
    BINKERT, C
    MARGOT, JB
    LANDWEHR, J
    HEINRICH, G
    SCHWANDER, J
    MOLECULAR ENDOCRINOLOGY, 1992, 6 (05) : 826 - 836
  • [6] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 IN FEMALE REPRODUCTIVE FUNCTIONS
    RUTANEN, EM
    SEPPALA, M
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1992, 39 (01) : 3 - 9
  • [7] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 AT MOUSE NEUROMUSCULAR SYNAPSES
    MA, JX
    YANG, SX
    HO, GJ
    FESTOFF, BW
    SYNAPSE, 1994, 17 (04) : 225 - 229
  • [8] DEXAMETHASONE INCREASES HEPATIC INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 EXPRESSION AND SERUM INSULIN-LIKE GROWTH-FACTOR BINDING-ACTIVITY
    LUO, JM
    MURPHY, LJ
    CLINICAL RESEARCH, 1990, 38 (02): : A454 - A454
  • [9] Immunoassay of insulin-like growth factor binding protein-1
    Khosravi, MJ
    Diamandi, A
    Mistry, J
    CLINICAL CHEMISTRY, 1997, 43 (03) : 523 - 532
  • [10] AGING IS ASSOCIATED WITH DECREASED SUPPRESSION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 BY INSULIN
    RUTANEN, EM
    KARKKAINEN, T
    STENMAN, UH
    YKIJARVINEN, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05): : 1152 - 1155